Phase III Study of Toripalimab(JS001) Combined With Lenvatinib for Advanced HCC
Phase III Study of Toripalimab(JS001) Combined With Lenvatinib for Advanced HCC
Active, not recruiting · NCT04523493 · Registry updated 2026-07-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase III Study of Toripalimab(JS001) Combined With Lenvatinib for Advanced HCC | Advanced Hepatocellular Carcinoma (HCC) | Active, not recruiting | Phase 3 | 2026-07-06 | NCT04523493 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Junshi Bioscience Co., Ltd. | 42 |
22 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.